In this case study, a patient with long-standing androgenic alopecia and lupus showed a satisfactory response to treatment with oral and topical minoxidil after suboptimal outcomes with previous treatments.
September 2025 in “Intisari Sains Medis” This case report from this study demonstrates the potential of treating severe alopecia areata with a combination of microneedling, minoxidil, desoximetasone, and methylprednisolone, noting initial hair regrowth after 14 days but emphasizing the need for further research to confirm long-term efficacy and safety.
August 2023 in “Anales de la Facultad de Ciencias Médicas” In this case study, a patient with longstanding androgenetic alopecia and systemic lupus erythematosus showed a positive response to both oral and topical minoxidil after suboptimal outcomes from previous treatments, highlighting the importance of timely diagnosis and management to reduce psychiatric risk factors.
3 citations
,
March 2022 in “Archives of Dermatological Research” This study reported that oral minoxidil was associated with clinical improvement in androgenetic alopecia and telogen effluvium, showing better outcomes compared to controls.
July 2025 in “The Journal of Dermatology” This study reported that 5% topical minoxidil lotion may be beneficial for enhancing hair regrowth in patients with telogen effluvium, although its effectiveness is limited by the self-healing nature of the condition and the small sample size.